ADMA icon

ADMA Biologics

13 hedge funds and large institutions have $66.8M invested in ADMA Biologics in 2014 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.

Holders
13
Holders Change
+12
Holders Change %
+1,200%
% of All Funds
0.35%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
12
Increased
1
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
AC
1
Aisling Capital
New York
$40.3M 3,608,171 +3,608,171 New
CCM
2
Consonance Capital Management
New York
$9.8M 877,407 +100,544 +13%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$4.73M 423,100 +423,100 New
BC
4
Broadfin Capital
New York
$4.35M 389,193 +389,193 New
Franklin Resources
5
Franklin Resources
California
$4.02M 360,137 +360,137 New
SCM
6
Sio Capital Management
New York
$2.75M 245,930 +245,930 New
TI
7
Telemetry Investments
New York
$749K 67,066 +67,066 New
US Bancorp
8
US Bancorp
Minnesota
$22K 2,000 +2,000 New
PCM
9
Prelude Capital Management
New York
$18K 1,600 +1,600 New
Morgan Stanley
10
Morgan Stanley
New York
$7K 666 +666 New
RC
11
RegentAtlantic Capital
New Jersey
$5.59K 500 +500 New
TRCT
12
Tower Research Capital (TRC)
New York
$2K 200 +200 New
Citigroup
13
Citigroup
New York
$0 3 +3 New